HK1112721A1 - Tissue disruption treatment and composition for use thereof - Google Patents

Tissue disruption treatment and composition for use thereof

Info

Publication number
HK1112721A1
HK1112721A1 HK08107834.7A HK08107834A HK1112721A1 HK 1112721 A1 HK1112721 A1 HK 1112721A1 HK 08107834 A HK08107834 A HK 08107834A HK 1112721 A1 HK1112721 A1 HK 1112721A1
Authority
HK
Hong Kong
Prior art keywords
composition
tissue disruption
disruption treatment
treatment
tissue
Prior art date
Application number
HK08107834.7A
Other languages
English (en)
Inventor
Jeffrey D Edwards
Maud Louisa Johanna Maria Eijkenboom
Original Assignee
Cambridge Scient Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Scient Pty Ltd filed Critical Cambridge Scient Pty Ltd
Publication of HK1112721A1 publication Critical patent/HK1112721A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/242—Gold; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK08107834.7A 2005-09-01 2008-07-16 Tissue disruption treatment and composition for use thereof HK1112721A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/218,382 US20070048387A1 (en) 2005-09-01 2005-09-01 Tissue disruption treatment and composition for use thereof
PCT/AU2006/001288 WO2007025351A1 (en) 2005-09-01 2006-09-01 Tissue disruption treatment and composition for use thereof

Publications (1)

Publication Number Publication Date
HK1112721A1 true HK1112721A1 (en) 2008-09-12

Family

ID=37804502

Family Applications (1)

Application Number Title Priority Date Filing Date
HK08107834.7A HK1112721A1 (en) 2005-09-01 2008-07-16 Tissue disruption treatment and composition for use thereof

Country Status (9)

Country Link
US (2) US20070048387A1 (xx)
EP (1) EP1933853B1 (xx)
JP (2) JP2009506992A (xx)
AU (1) AU2006287128B2 (xx)
CA (1) CA2624316A1 (xx)
DK (1) DK1933853T3 (xx)
HK (1) HK1112721A1 (xx)
NZ (1) NZ567057A (xx)
WO (1) WO2007025351A1 (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2308954C2 (ru) * 2002-05-09 2007-10-27 Медиджинез Фармацевтическая композиция для лечения ран, содержащая плазму или сыворотку крови
EP2032147A4 (en) * 2006-04-28 2011-02-02 Cambridge Scient Pty Ltd INHIBITOR OF COX-2 ENZYME
WO2007124540A1 (en) * 2006-04-28 2007-11-08 Cambridge Scientific Pty Ltd Cytokine mediating composition
ITBO20090070A1 (it) * 2009-02-12 2010-08-12 Monica Bonucci Farmaco per la stomatite aftosa
WO2016168993A1 (en) 2015-04-22 2016-10-27 Innolife Co., Ltd. Methods of tissue repair and regeneration
EP3378935B1 (en) * 2015-11-16 2020-09-02 Kenichi Yamahara Bovine serum composition and method for culturing cells using said bovine serum composition as additive
CN114796630A (zh) * 2016-05-31 2022-07-29 瑞士奥克特珐玛公司 基于血浆的膜及其制造和使用方法
JP2022505915A (ja) 2018-10-26 2022-01-14 アルカヘスト，インコーポレイテッド 疼痛、創傷治癒及び術後回復の改善のための血漿及び血漿画分の使用
CA3151943A1 (en) * 2019-11-04 2021-05-14 Viktoria Kheifets Blood plasma fractions for use in muscle regeneration

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2579367A (en) * 1950-11-24 1951-12-18 Hynson Westcott & Dunning Inc Bandage
GB931016A (en) * 1960-12-22 1963-07-10 Distillers Co Yeast Ltd Amino acids concentrate and intravenous preparations thereof
JPS5220524B1 (xx) * 1968-11-02 1977-06-04
EP0061556B1 (en) * 1979-11-16 1984-10-03 AB Pripps Bryggerier Hemiron-enriched amino acid preparation and a process for the preparation of hemiron-enriched amino acid preparations from hemproteins
US4351710A (en) 1980-01-10 1982-09-28 Ionics, Incorporated Fractionation of protein mixtures
US4322275A (en) 1980-01-10 1982-03-30 Ionics Incorporated Fractionation of protein mixtures
HUT40311A (en) * 1983-06-03 1986-12-28 Kiskunhalasi Aag Process for producing protein concentrates, blood-curd and nutriments from blood and its elements
HUT37342A (en) * 1983-10-17 1985-12-28 Caola Kozmetikai Process for production of preparatives for medical cosmetics
US5138034A (en) 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
FR2651679B1 (fr) * 1989-09-08 1994-06-03 Imedex Application d'hydrolysats de globines pour la stimulation cellulaire et produits pharmaceutiques et cosmetiques obtenus.
ES2108110T3 (es) * 1991-03-01 1997-12-16 Atherton Investments Ltd Composiciones terapeuticas y cosmeticas para el tratamiento de la piel.
US5888522A (en) * 1996-08-23 1999-03-30 Skin Biology, Inc. Tissue protective and regenerative compositions
JP3578627B2 (ja) * 1998-05-15 2004-10-20 株式会社ホギメディカル 創傷患部の治癒を促進する組織シーラント
RU2221456C1 (ru) * 2003-03-11 2004-01-20 Общество с ограниченной ответственностью "Арсентех" Биологически активное вещество, биологически активная добавка к пище, фармацевтический препарат, биологически активная добавка для кормления животных, ветеринарный препарат, удобрение, активатор микробиологических процессов, пероральное питание, парфюмерно-косметическое средство, гигиеническое средство, молочный продукт, кондитерское изделие, хлебобулочное изделие, масло-жировой продукт, соус, алкогольный напиток, безалкогольный напиток, рыбный продукт, мясной продукт, макаронные изделия, жевательная резинка, пиво
US20040197319A1 (en) * 2003-03-24 2004-10-07 Paul Harch Wound healing composition derived from low platelet concentration plasma
US7510732B2 (en) * 2005-02-16 2009-03-31 Cambridge Scientific Pty Ltd Analgesic and anti-inflammatory composition
EP1853281A4 (en) 2005-02-11 2010-07-14 Cambridge Scient Pty Ltd ANALGESIC AND ANTI-INFLAMMATORY PREPARATION

Also Published As

Publication number Publication date
AU2006287128A1 (en) 2007-03-08
JP2009506992A (ja) 2009-02-19
EP1933853A4 (en) 2010-03-17
NZ567057A (en) 2010-08-27
EP1933853B1 (en) 2013-07-17
DK1933853T3 (da) 2013-10-07
US20150064164A1 (en) 2015-03-05
US20070048387A1 (en) 2007-03-01
CA2624316A1 (en) 2007-03-08
AU2006287128B2 (en) 2011-10-06
JP2015057439A (ja) 2015-03-26
WO2007025351A1 (en) 2007-03-08
EP1933853A1 (en) 2008-06-25

Similar Documents

Publication Publication Date Title
HK1112721A1 (en) Tissue disruption treatment and composition for use thereof
ATE456369T1 (de) Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen
MX2012002746A (es) Vendajes medicos antimicrobianos y proteccion de heridas y sitios de cateter.
MX2010003258A (es) Utilizacion de un nuevo agente natural en composiciones cosmeticas.
EP1880719A3 (en) Composition for prophylaxis or treatment of urinary system infection and method thereof
HK1122803A1 (xx)
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
WO2010078883A3 (de) Kombinierte desinfektions- und dekontaminationsmittel mit erhöhter wirksamkeit
EP1969120A4 (en) COMPOSITIONS AND TREATMENTS FOR SKIN CARE
PL2210588T3 (pl) Kompozycje pianotwórcze do leczenia skóry ludzkiej zasadniczo niezawierające aktywnych składników farmaceutycznych
MX2007010560A (es) Roflumilast para el tratamiento de diabetes mellitus.
ITMI20041550A1 (it) Uso di batteri probiotici per la preparazione di composizioni topiche per la protezione dell'epidermide
WO2009040420A3 (en) Use of a monoterpene to increase tissue repair
WO2010006219A3 (en) Use of scaffold comprising fibrin for delivery of stem cells
TW200716091A (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
HK1124546A1 (en) Use of benzo-fused heterocycle sulfamide derivatives for the treatment of mania and bipolar disorder
WO2009079451A3 (en) Compositions and methods of promoting wound healing
WO2008010991A3 (en) Methods and compositions for the treatment of cancer
PL2465493T3 (pl) Kompozycje do stosowania miejscowego do profilaktyki i leczenia podrażnienia błon komórek
EP2079526A4 (en) COMPOSITIONS AND ITS USES IN THE TREATMENT OF WOUNDS
MX2010005012A (es) Composiciones para el tratamieno y prevencion de inflamacion de los parpados que comprenden un ingrediente osmoticamente activo y un vasocosntrictor.
WO2006094070A3 (en) Human skin equivalents expressing exogenous polypeptides
MX2012006629A (es) Microorganismos probioticos como agentes activos contra cambios en microrelieve de la piel.
WO2008112773A3 (en) Droxidopa and pharmaceutical composition thereof for the treatment of neurally mediated hypotension
MX2009002224A (es) Composicion a base de xantoxilina y su utilizacion en cosmetica.

Legal Events

Date Code Title Description
AM Amended specification (according sect 146 of patent law)

Free format text: DELETION OF INVENTOR: PALERMO, JOHN

PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170901